Skip to Content Skip to Navigation
JDRF is now Breakthrough T1D – welcome to our next chapter. Learn about our evolution.

We want to make living with type 1 diabetes easier and safer

Research to improve lives

That’s why we’re investing in research to make blood glucose management easier, reduce health complications and improve mental health.

We will do this through our three research priorities:

Managing blood glucose levels

Making blood glucose management easier and safer

Illustrated icon of an insulin pump

Complications

Reducing the long-term health impacts of living with T1D

BreakthroughT1D Icon_Blues_RGB__Eye + Kidney

Behavioural health

Strategies to improve the mental health and quality of life of people with T1D

BreakthroughT1D Icon_Blues_RGB__Psychology + T1D (1)

Making blood glucose management easier and safer

Managing blood glucose levels

While current dugs and technologies make living with T1D easier than in the past, we know that keeping blood glucose levels in the target range remains a daily challenge for people with the condition.

That’s why we’re funding research into new type 1 diabetes treatments. This includes new technologies that more closely mimic the natural workings of the pancreas, as well as better drugs – including new forms of insulin – to better manage blood glucose.

We’re working on the next generation of glucose-responsive insulins, smarter and smaller devices and combining other drugs to dramatically improve blood glucose management.

A woman wearing a CGM on her left arm. She looks at her phone. Her face is not visible

Reducing the long-term health impacts of living with type 1 diabetes

Complications

In Australia, around 40% of people living with T1D have developed at least one long-term health complication due to the condition.

We’re supporting the development of new treatments and drugs and establishing clinical trials to prevent or reverse the damage that comes with living with T1D.

Our focus is funding research projects that reduce the impact of T1D on eye, kidney and heart disease.

Image of a woman having her eye health tested at the optometrist

Strategies to improve the mental health and quality of life of people with T1D

Behavioural health

People living with T1D and their families face unique challenges in managing the condition that can often lead to anxiety, depression and other mental health conditions.

We’re supporting research to ease this mental burden and improve the quality of life of those affected by T1D and their loved ones.

Woman with insulin pump clipped to her shorts, smiling at the camera.

FAQs about research to improve lives

We answer the most important questions about our research program to bring new type 1 diabetes treatments and improve lives for those affected by the condition

Finding cures for T1D is core to our mission. But while we work to ensure this happens as quickly as possible, we’re committed to improving the lives of people who live with T1D.

This applies whether you’re newly diagnosed or have been living with the condition for many years.

We’re bringing new type 1 diabetes treatments in the following 3 areas:

1. New and better ways to manage blood glucose levels through better insulins and glucagons and better technologies such as insulin pumps, sensors, algorithms and combination therapies.

2. Treatments for eye, kidney and heart disease to reduce the number of long-term health complications that often arise from living with T1D.

3. Developing new interventions to improve the mental health and quality of life of people with T1D.

T1D is a condition that requires care 24 hours a day, 365 days a year. There are no ‘rest’ days.

The relentless nature of the condition means that people living with T1D and those around them are at increased risk of suffering from mental health conditions such as anxiety, depression and disordered eating. Living with T1D can also generate social stigma.

That’s why we’re investing in research programs to address the mental health burden that can come with having T1D.

Unfortunately, living with T1D for a longer time can lead to long-term impacts on organs around the body.

In Australia, around 40% of people living with T1D have developed at least one long-term health complication due to the condition. The most common complications are nerve damage, heart disease and kidney disease.

We fund research programs that look to prevent or better treat these conditions. Our focus is on improved treatments for eye, kidney and heart disease.

The best way to keep up to date with research news from Breakthrough T1D-funded research is to follow our socials and sign up to our research newsletter: Game Changer. You can subscribe to this via the form at the bottom of this page.

We want to improve the lives of those with type 1 diabetes. Will you join us?

Help us improve the lives of those with T1D

Your donations help us fund projects in the most promising areas of T1D research. Will you donate today to help us keep pushing for a cure for T1D and improve lives?

banner home mobile

Research news

The ultra long-acting insulin Tresiba is now listed on the PBS

Research news

Tresiba, also known as insulin degludec, is now subsidised by the Australian Government.

tresiba penfill

Tzield updates from the US and UK

Research news

A look at how access to Tzield, the first new therapy for type 1 diabetes (T1D) since insulin, is expanding for more people around the world.

a vial of Tzield

Tzield in Australia: your FAQs answered

Research news

Find answers to frequently asked questions about Tzield, the first drug approved to treat type 1 diabetes (T1D) since insulin.

Jess Kovacs getting Tzield

What is the Eledon trial?

Research developments

Learn about the Eledon trial and why it marks a promising step towards making islet transplants safer and more accessible for people with type 1 diabetes (T1D). 

Close-up view of blue spherical cells.

Type1Screen: Screening for early-stage type 1 diabetes in family members

Research news

Breakthrough T1D funds a program where family members of those with type 1 diabetes can be screened for early signs of the condition.

Photo of a little boy looking at the camera, He has just done a finger prick test and on the table in front of him rests a card with 4 blood spots. He is wearing a bandaid on his right thumb

Tzield is now approved in Australia

Research news

This is the first new therapy approved for T1D in over 100 years, since the discovery of insulin.

A small vial of Tzield

Research insights from a meeting of top international diabetes scientists in Australia

Research news

Global experts gathered in Brisbane this April for the Immunology of Diabetes Society (IDS) Congress, sharing the latest breakthroughs in type 1 diabetes (T1D) research. Here are our key highlights.

IDS 2026 April Breakthrough T1D stall

Stay updated

Get the latest type 1 diabetes news

Whether you're interested in research updates, events, our latest resources or advocacy news, there's a Breakthrough T1D newsletter to suit you. Sign up today!






Man with beard wearing a blue shirt holding a little girl with her thumbs up